脊柱肌肉缩中的生物标志物
Liping Yan1, Jinping Zhang2, Jian Zheng3
1Department of Pathology, Second Affiliated Hospital of Nanchang University, Nanchang, China.
Frontiers in neurology
|August 4, 2025
概括
生物标志物对于脊柱肌缩 (SMA) 管理至关重要,有助于诊断和监测新疗法. 本综述详细介绍了当前和新兴的生物标志物,以改善治疗决策.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 生物标志物研究 生物标志物研究
背景情况:
- 脊椎肌肉缩 (SMA) 是一种严重的遗传神经肌肉疾病.
- 疾病修饰疗法已经改变了SMA的管理.
- 生物标志物对于SMA的诊断,预后和治疗监测至关重要.
研究的目的:
- 系统地审查脊柱肌肉缩的生物标志物.
- 为了总结经典和新型生物标志物.
- 讨论SMA临床决策中的生物标志物的实用性.
主要方法:
- 科学文献的系统审查.
- 从人类患者和动物模型中分析生物标志物.
- 生物标志物的分类为生理,功能,成像和分子类型.
主要成果:
- 在当前的 SMA 临床实践中使用的已确定的生物标志物.
- 从最近的研究中突出的新兴生物标志物.
- 讨论了表达模式,临床相关性和各种生物标志物的应用.
结论:
- 生物标志物对于对SMA患者进行分层至关重要.
- 准确的生物标志物评估有助于预测治疗疗效.
- 生物标志物支持脊柱肌肉缩的个性化治疗策略.
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Myasthenia Gravis: Diagnostic Tests
1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K


